InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [08/11/2025 12:42 PDT] InterCure Ltd. (NASDAQ:INCR), Up By 100% ($1.5) From $1.5 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/11/2025 12:23 PDT] InterCure Ltd. (NASDAQ:INCR), Up By 100% ($1.46) From $1.455 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/06/2025 07:28 PDT] INCR Expected to Trade Up After Bullish Patterns Develop
• [08/05/2025 07:19 PDT] INCR Expected to Trade Up After Bullish Patterns Develop
• [08/01/2025 14:55 PDT] InterCure Ltd. (NASDAQ:INCR), Down By 100% ($1.6) From $1.6 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [07/15/2025 09:14 PDT] INCR Expected to Trade Down After Bearish Patterns Develop
• [07/09/2025 07:31 PDT] INCR Expected to Trade Down After Bearish Patterns Develop